Siolta Therapeutics is an early stage, venture-backed biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases. Located in the historic Dogpatch area of San Francisco, we are a part of the innovative incubator program offered by QB3@953.